Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Deferred Tax Liability: 2018-2024

Historic Non-Current Deferred Tax Liability for OptimizeRx (OPRX) over the last 7 years, with FY2024 value amounting to $4.5 million.

  • OptimizeRx's Non-Current Deferred Tax Liability rose 6559.73% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 6559.73%. This contributed to the annual value of $4.5 million for FY2024, which is 355.08% up from last year.
  • OptimizeRx's Non-Current Deferred Tax Liability amounted to $4.5 million in FY2024, which was up 355.08% from $4.3 million recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Non-Current Deferred Tax Liability peaked at $4.5 million during FY2024, and registered a low of $2.3 million during FY2020.
  • Its 5-year average for Non-Current Deferred Tax Liability is $3.2 million, with a median of $2.6 million in 2021.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first crashed by 1106.87% in 2022, then skyrocketed by 8613.73% in 2023.
  • OptimizeRx's Non-Current Deferred Tax Liability (Annual) stood at $2.3 million in 2020, then rose by 14.36% to $2.6 million in 2021, then fell by 11.07% to $2.3 million in 2022, then skyrocketed by 86.14% to $4.3 million in 2023, then increased by 3.55% to $4.5 million in 2024.
  • Its last three reported values are $4.5 million in FY2024, $4.3 million for FY2023, and $2.3 million during FY2022.